P34 Non-systemic treatment of metastatic kidney cancer

P34 Non-systemic treatment of metastatic kidney cancer

Saved in:

Bibliographic Details
Main Authors:	G.O. Morkunaite, U. Mickeviciute, M. Trakymas, M. Kincius, V. Urbonas, G. Kvederas, A. Patasius
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325002125
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

P34. The Financial Burden of Lymphedema Treatment on the Patient
by: Shayan M. Sarrami, MD, et al.
Published: (2025-05-01)

Serum NLRP3 and S1P as Potential Diagnostic and Prognostic Biomarkers in Female Metastatic and Non-Metastatic Breast Cancer Patients
by: Anas R. Soltan, et al.
Published: (2023-12-01)

ROLE OF TARGETED THERAPY IN THE COMBINATION TREATMENT OF PATIENTS WITH KIDNEY CANCER AND METASTATIC BRAIN INVOLVEMENT
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

COMPARATIVE IMMUNOHISTOCHEMICAL EVALUATION OF E-CADHERIN AND Β-KATENIN EXPRESSION IN METASTATIC AND NON-METASTATIC BREAST CANCER OF NON-SPECIFIC TYPE
by: M. V. Mnikhovich, et al.
Published: (2018-08-01)

CLINICAL CASE OF MULTIMODALITY TREATMENT OF METASTATIC BLADDER CANCER
by: A. V. Lykov, et al.
Published: (2020-01-01)

Modalism Revisited: A Defence
by: Monika Morkūnaitė
Published: (2024-12-01)

Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014-08-01)

Systemic treatment for metastatic prostate cancer
by: Gwenaelle Gravis
Published: (2019-04-01)

Treatment sequencing in metastatic colorectal cancer
by: Nanteznta Torounidou, et al.
Published: (2025-01-01)

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
by: Goran Bencina, et al.
Published: (2023-06-01)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
by: Tetsuro Kawagoe, et al.
Published: (2020-01-01)

PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
by: A. U. Kulikov
Published: (2015-03-01)

MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer
by: Takashi Oda, et al.
Published: (2024-03-01)

Variability in surgical treatment of metastatic colorectal cancer (literature review)
by: A. Yu. Dobrodeev, et al.
Published: (2023-05-01)

Non-invasive actionable biomarkers for metastatic prostate cancer
by: Jun Luo
Published: (2016-10-01)

Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
by: Eileen Morgan, et al.
Published: (2024-11-01)

Role of sirtuin 1 (SIRT1) gene polymorphisms in pituitary adenoma development. Literature review
by: G. Morkūnaitė, et al.
Published: (2018-06-01)

Molecular Signature of miR-34a/NEAT-1/p53 Axis in Mycosis Fungoides
by: Reham Fares, et al.
Published: (2024-01-01)

Costs of non-metastatic prostate cancer treatment among privately insured men in the United States
by: Ashley J. Housten, et al.
Published: (2025-01-01)

Metastatic brain lesions in prostate cancer
by: P. G. Berezin, et al.
Published: (2025-06-01)

METASTATIC HEAD AND NECK CANCER WITH UNKNOWN PRIMARY: DIAGNOSIS AND TREATMENT
by: M.I. SOKOLOVA, et al.
Published: (2025-03-01)

Advances in the treatment of metastatic prostate cancer in China
by: Baojun Wang, et al.
Published: (2025-05-01)

CONTEMPORARY TRENDS IN THE TREATMENT OF METASTATIC BREAST CANCER
by: V. I. Borisov
Published: (2014-09-01)

WHAT’S NEW IN METASTATIC COLON CANCER TREATMENT?
by: Senem Karabulut, et al.
Published: (2021-07-01)

Surgical treatment of metastatic germ cell cancer
by: Andreas Hiester, et al.
Published: (2021-04-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic Review
by: Toni Zhong, et al.
Published: (2025-04-01)

P37 Impact of surgical margins on overall and cancer-specific survival in kidney cancer patients
by: G. Šulskus, et al.
Published: (2025-07-01)

Influence of chemiotherapeutic protocol and neuroendocrine differentiation on metastatic non-small cell lung cancer treatment results
by: Tomić Ilija, et al.
Published: (2007-01-01)

Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer.
by: Deborah R Kaye, et al.
Published: (2016-01-01)

Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials
by: R.-D. Hofheinz, et al.
Published: (2016-01-01)

Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)

Immunotherapy in metastatic prostate cancer
by: Liam Dwyer, et al.
Published: (2025-06-01)

Comparison of two combined drug therapy regimens for renal damage in patients with metastatic kidney cancer after previously performed unilateral nephrectomy
by: K. S. Titov, et al.
Published: (2025-06-01)

TREATMENT OF BREAST CANCER WITH METASTATIC CONTRALATERAL AXILLARY LYMPH NODES: CASE REPORT AND LITERATURE REVIEW
by: V. A. Amosova, et al.
Published: (2020-01-01)

A Biomarker for Metastatic Colorectal Cancer and Treatment Goals
by: Aru W Suydoyo
Published: (2016-05-01)

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?
by: Joanne Chiu, et al.
Published: (2012-01-01)

A Biomarker for Metastatic Colorectal Cancer and Treatment Goals
by: Aru W Suydoyo
Published: (2016-05-01)

Chapter 34: Pepper Production in Florida
by: Stephen M. Olson, et al.
Published: (2019-05-01)